Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis.
NCT05725876
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
56
Enrollment
OTHER
Sponsor class
Conditions
Psoriasis
Crohn Disease
Interventions
DRUG:
Ustekinumab
Sponsor
University Medical Center Groningen